Yellow fever;Febre amarela

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 36, Issue 2, 2003, Pages 275-293

  Da Costa Vasconcelos, Pedro Fernando ^a  

^a INSTITUTO EVANDRO CHAGAS   (Brazil)

Author keywords

Aedes; Hepatitis; Jaundice; Vaccine; Yellow fever

Indexed keywords

17D VACCINE; ACETYLSALICYLIC ACID DERIVATIVE; ANALGESIC AGENT; ANTIEMETIC AGENT; ANTIPYRETIC AGENT; CIMETIDINE; FUROSEMIDE; HISTAMINE H2 RECEPTOR ANTAGONIST; IMMUNOGLOBULIN M; MANNITOL; METOCLOPRAMIDE; OMEPRAZOLE; RANITIDINE; RIBAVIRIN; UNCLASSIFIED DRUG; YELLOW FEVER VACCINE;

AEDES; AFRICA; BOLIVIA; BRAZIL; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE SEVERITY; DRUG FATALITY; ENCEPHALITIS; EPIDEMIC; HAEMAGOGUS; HUMAN; IMMUNOHISTOCHEMISTRY; MORTALITY; MOSQUITO; PATHOGENESIS; PERU; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SABETHES; SERODIAGNOSIS; SIDE EFFECT; SOUTH AMERICA; VACCINATION; VIRUS ISOLATION; VIRUS TRANSMISSION; YELLOW FEVER; YELLOW FEVER FLAVIVIRUS; ZOONOSIS;

ARBOVIRUS; FLAVIVIRUS; HAEMAGOGUS; PRIMATES; SABETHES; VERTEBRATA; YELLOW FEVER VIRUS;

EID: 0037523545     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0037-86822003000200012     Document Type: Review

References (70)

1. Barrett ADT. Yellow fever vaccines. Biologicals 25:17-25, 1997.
2. Bearcroft WGC. The histopathology of the liver of yellow fever-infected Rhesus monkeys. Journal Pathology of Bacteriology 74:295-303, 1957.
3. th edition. American Public Health Association, Washington, p. 797-855, 1989.
4. Benchimol JL. Febre amarela: A doença e a vacina, uma história inacabada. Editora FIOCRUZ, Rio de Janeiro, 2001.
5. Brés PLJ. A century of progress in combating yellow fever. Bulletin of the World Health Organization 64:775-786, 1986.
6. Carmo EH, Martins E, Pelucci HH, Mala ML, Duzzi R, Tuboi S, Costa ZG. Brote de fiebre amarilla selvática en Minas Gerais, Brasil. Boletin Informativo PAI, Organización Pan-Americana de la Salud, Washington, 24:5-6, 2002.
7. Chambers TJ, Hahn CS, Galler R, Rice CM. Flavivirus genome organization, expression, and replication. Annual Reviews of Microbiology 44:649-488, 1990.
8. Chan RC, Penney DJ, Little D, Carter IW, Roberts JA, Rawlinson WD. Hepatitis and death following vaccination with 17D-204 yellow fever vaccine. Lancet 358:121-122, 2001.
9. Costa ZGA, Oliveira RC, Tuboi SH, Silva MM, Vasconcelos PFC. Redefinição das áreas de risco para febre amarela silvestre no Brasil. Revista da Sociedade Brasileira de Medicina Tropical 35 (supl I): 84, 2002.
10. Dégallier N, Travassos da Rosa APA, Hervé JP, Travassos da Rosa JFS, Vasconcelos PFC, Mangabeira da Silva CJ, Barros VLRS, Dias LB, Travassos da Rosa ES, Rodrigues SG. A comparative study of yellow fever in Africa and South America. Brazilian Journal of the Association for Advancement of Science 44:143-161, 1992a.
11. Dégallier N, Travassos da Rosa APA, Vasconcelos PFC, Travassos da Rosa ES, Rodrigues SG, Sá Filho GC, Travassos da Rosa JFS. New entomological and virological data on the vectors of sylvatic yellow fever in Brazil. Brazilian Journal of the Association for Advancement of Science 44:136-142, 1992b.
12. Dégallier N, Travassos da Rosa APA, Vasconcelos PFC, Figueiredo LTM, Travassos da Rosa JFS, Rodrigues SG, Travassos da Rosa ES. La dengue et ses vecteurs au Brésil. Bulletin de la Société de Pathologie Exotique 89:128-136, 1996.
13. Digoutte JP, Cornet M, Deubel V, Downs WG. Yellow fever. In: Porterfield JS (ed) Exotic Viral Infections, Chapman + Hall Medical, London, p. 67-102, 1995.
14. Dutary BE, Leduc JW. Transovarial transmission of yellow fever virus by a sylvatic vector. Transactions of the Royal Society of Tropical Medicine and Hygiene 75:128, 1981.
15. Franco O. História da febre amarela no Brasil. Departamento Nacional de Endemias Rurais, Ministério da Saúde, Rio de Janeiro, 1969.
16. Fundação Nacional de Saúde. Plano de Intensificação de controle da febre amarela no Brasil. Fundação Nacional de Saúde, Basília (Mimeografado), 2001.
17. Galler R, Pugachev KV, Santos CLS. Ochran SW, Jabor AV, Rodrigues SG, Marchevsky RS, Freire MS, Almeida LFC, Cruz ACR, Yamamura AMY, Rocco IM, Rosa EST, Souza LTM, Vasconcelos PFC, Guirakhoo F, Monath TP. Phenotypic and molecular analyses of yellow fever 17DD vaccine viruses associated with serious adverse events in Brazil. Virology 290:309-319, 2001.
18. Groot H, Bahia-Ribeiro R. Neutralizing and haemagglutination-inhibiting antibodies to yellow fever 17 years after vaccination with 17D vaccine. Bulletin of the World Health Organization 27:699-707, 1962.
19. Hall WC, Crowell TP, Watts DM, Barros VLR, Kruger H, Pinheiro FP, Peters CJ. Demonstration of yellow fever and dengue antigens in formalin-fixed paraffin-embedded human liver by immunohistochemical analysis. American Journal of Tropical Medicine and Hygiene 45:408-17, 1991.
20. Jennings AD, Gibson CA, Miller BR, Matthews JH, Mitchell CJ, Roehrig JT, Wood DJ, Taffs F, Sil BK, Whitby SN, Minor PD, Monath TP, Barrett ADT. Analysis of a yellow fever virus isolated from a fatal case of vaccine-associated human encephalitis. Journal of Infectious Diseases 169:512-518, 1994.
21. Jones EMM, Wilson DC. Clinical features of yellow fever cases at Vom Christian Hospital during the 1969 epidemic on the Jos Plateau, Nigeria. Bulletin of the World Health Organization 46:653-657, 1972.
22. Kelso JM, Mootrey GT, Tsai TS. Anaphylaxis from yellow fever vaccine. Journal of Allergy Clinical and Immunology 103: 698-701, 1999.
23. Kerr JA. The clinical aspects and diagnosis of yellow fever. In: Strode GK (ed) Yellow fever, McGraw-Hill, New York, p. 385-425, 1951.
24. Kuno G, Gomez I, Gubler DJ. Detecting artificial antidengue IgM complexes using a enzyme linked immunosorbent assay. American Journal of Tropical Medicine and Hygiene 36:153-159, 1987.
25. Lanciotti RS, Calisher CH, Gubler DJ, Chang G-J, Vorndam V. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. Journal of Clinical Microbiology 30:545-551, 1992.
26. Martin M, Tsai TF, Cropp B, Chang GJJ, Holmes DA, Tseng J, Shieh WJ, Zaki SR, Al-Sanouri I, Cutrona AF, Ray G, Weld LH, Cetron MS. Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases. Lancet 358:98-104, 2001.
27. Miller BR, Monath TP, Tabachnick WJ, Ezike VI. Epidemic yellow fever caused by an incompetent mosquito vector. Tropical Medicine and Parasitology 40:396-399, 1989.
28. Monath TP. Yellow fever: a medically neglected infectious disease. Reviews of Infectious Diseases 9:165-175, 1987.
29. Monath TP. Yellow fever. In: Monath TP (ed) Arboviruses: ecology and epidemiology, Volume. V, CRC Press, Boca Raton, p.139-241, 1988.
30. Monath TP. Epidemiology of yellow fever: current status and speculations on future trends, Saluzzo JF, Dodet B (ed). In: Factors in the Emergence of Arbovirus Diseases, Elsevier, Paris, p. 143-156, 1997.
31. Monath TP. Yellow fever: An update. Lancet Infectious Diseases 1:11-20, 2001.
32. Monath TP, Brinker KR, Chandler FW, Kemp GE, Cropp CB. Pathophysiologic correlations in a rhesus monkey model of yellow fever: with special observations on the acute necrosis of B cell areas of lymphoid tissues. American Journal of Tropical Medicine and Hygiene 30:431-443, 1981.
33. Mondet B, Travassos da Rosa APA, Vasconcelos PFC. Les risques d'épidémisation urbaine de la fièvre jaune au Brésil Aedes aegypti et Aedes albopictus. Bulletin de la Société de Pathologie Exotique 89:107-114, 1996.
34. Mondet B, Vasconcelos PFC, Travassos da Rosa APA, Travassos da Rosa ES, Rodrigues SG, Travassos da Rosa JFS, Bicout DJ. Isolation of Yellow Fever Virus from Nulliparous Haemagogus (Haemagogus) janthinomys in Eastern Amazonia. Vectorborne and Zoonotic Diseases 2: 47-50, 2002.
35. Mutebi JP, Wang H, Li L, Bryant JE, Barrett ADT. Phylogenetic and evolutionary relationships among yellow fever virus isolates in Africa. Journal of Virology 75:6999-7008, 2001.
36. Nasidi A, Monath TP, Vanderberg J. Yellow fever vaccination and pregnancy: a four-year prospective study. Transactions of the Royal Society of Tropical Medicine and Hygiene 87:337-339, 1993.
37. Nobre A, Antezana D, Tauil PL. Febre amarela e dengue no Brasil: epidemiologia e controle. Revista da Sociedade Brasileira de Medicina Tropical 27 (supl III):59-66, 1994.
38. Oudart JL, Rey M. Protéinurie, protéinémie et transaminasémies dans 23 cas de fievre jaune confirmée. Bulletin of the World Health Organization 42:95-101, 1970.
39. Pan American Health Organization - PAHO. Casos y muertes por fiebre amarilla en región de las Américas. Pan American Health Organization, Washington, 2002.
40. a ed, Editora Guanabara-Koogan, Rio de Janeiro, p. 303-314, 1983.
41. Pinheiro FP, Travassos da Rosa APA, Moraes MAP, Neto JCA, Camargo S, Filgueiras FP. An epidemic of yellow fever in central Brazil, 1972-1973. I. Epidemiological studies. American Journal of Tropical Medicine and Hygiene 27:125-132, 1978.
42. Poland JD, Calisher CH, Monath TP, Downs WG, Murphy K. Persistence of neutralizing antibody 30-35 years after immunization with 17D yellow fever vaccine. Bulletin of World Health Organization 59:895-900, 1981.
43. Rice CM, Lenches EM, Eddy SR, Shin SH, Strauss JH. Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution. Science 229:726-733, 1985.
44. Robert E, Vial T, Schaefer C, Arnon J, Reuvers M. Exposure to yellow fever vaccine in early pregnancy. Vaccine 17:283-285, 1999.
45. Robertson SE. The immunological basis for immunization series: Yellow fever. World Health Organization (Document WHO/EPI/GEN/93.18), Geneva, 1993.
46. Robertson SE, Hull BP, Tomori O, Bele O, LeDuc JW, Esteves K. Yellow Fever. A decade of reemergence. Journal of the American Medical Association 276:1157-1162, 1996.
47. Santos F. Dosagem dos fatores da coagulação na febre amarela. Tese de Doutorado, Universidade Federal do Rio de Janeiro, Rio de Janeiro, 1973.
48. Serié C, Lindrec A, Poirier A, Andral L, Neri P. Etudes sur la fievre jaune em Ethiopie. I. Introduction et simptomatologie clinique. Bulletin of the World Health Organization 38:835-841, 1968.
49. Soper FL. Jungle yellow fever: new epidemiological entity in South America. Revista de Hygiene e Saúde Pública 10:107-144, 1936.
50. Strode GK. Yellow fever. New York: McGraw-Hill, 1951.
51. Taylor RM. Epidemiology. In: Strode GK (ed) Yellow fever. McGraw-Hill, New York, p. 427-459, 1951.
52. Tesh RB, Guzman H, Travassos da Rosa APA, Vasconcelos PFC, Dias LB, Bunnell JE, Zhang H, Xiao SY. Experimental yellow fever virus infection in the Golden Hamster (Mesocricetus auratus). 1. Virologic, Biochemical and Immunologic studies. Journal of Infectious Diseases 183:1431-1436, 2001.
53. Tigertt WD, Berge TO, Gochenour WS, Gleiser CA, Eveland WC, Bruegge CV, Smetana HF. Experimental yellow fever. Transactions of the New York Academy of Science 22:323-333, 1960.
54. Tsai TF, Paul R, Lynberg MC, Letson GW. Congenital yellow fever virus infection after immunization in pregnancy. Journal of Infectious Diseases 168:1520-1523, 1993.
55. Van der Stuyft P, Gianella A, Pirard M, Cespedes J, Lora J, Peredo C, Pelegrino JL, Vorndam V, Boelaert M. Urbanisation of yellow fever in Santa Cruz, Bolivia. Lancet 353:1558-1562, 1999.
56. Vanio J, Cutts F. Yellow fever. World Health Organization. Document WHO/EPI/GEN/18.11, Geneva, 1998.
57. Vasconcelos PFC. Febre amarela. Sociedade Brasileira de Pediatria, Rio de Janeiro, 2000.
58. Vasconcelos PFC, Costa ZG, Travassos da Rosa ES, Luna E, Rodrigues SG, Barros VLRS, Dias JP, Monteiro HAO, Oliva OFP, Vasconcelos HB, Oliveira RC, Sousa MRS, Barbosa da Silva J, Cruz ACR, Martins EC, Travassos da Rosa JFS. An epidemic of jungle Yellow fever in Brazil, 2000. Implications of climatic alterations in disease spread. Journal of Medical Virology 65:598-604, 2001.
59. Vasconcelos PFC, Luna EJ, Galler R, Silva LJ, Coimbra TL, Barros VLR, Monath TP, Rodrigues SG, Laval C, Costa ZG, Vilela MFG, Santos CLS, Papaiordanou CM, Alves VAF, Andrade LD, Sato HK, Rosa EST, Froguas GB, Lacava E, Almeida LMR, Cruz ACR, Rocco IM, Santos RTM, Oliva OFP. Serious adverse events associated with yellow fever 17DD vaccine in Brazil: Report of two cases. Lancet 358:91-97, 2001.
60. Vasconcelos PFC, Rodrigues SG, Dégallier N, Moraes MAP, Travassos da Rosa JFS, Travassos da Rosa ES, Mondet B, Barros VLRS, Travassos da Rosa APA. An epidemic of sylvatic yellow fever in the southeast region of Maranhão State, Brazil, 1993-1994: epidemiologic and entomologic findings. American Journal of Tropical Medicine and Hygiene 57:132-137, 1997.
61. Vasconcelos PFC, Sperb AF, Monteiro HAO, Torres MAN, Souza MRS, Vasconcelos HB, Mardini LBLF, Rodrigues SG. Isolations of yellow fever virus from Haemagogus leucocelaenus in Rio Grande do Sul State, Brazil, in the Southern Cone. Transactions of the Royal Society of Tropical Medicine and Hygiene 97, 2003.
62. Vasconcelos PFC, Travassos da Rosa APA, Pinheiro FP, Dégallier N, Travassos da Rosa JFS. Febre amarela. In: Leão RNQ (ed) Doenças Infecciosas e Parasitárias. Enfoque Amazônico. Editora CEJUP, Belém, p. 265-284,1997.
63. Vasconcelos PFC, Travassos da Rosa APA, Pinheiro FP, Rodrigues SG, Travassos da Rosa ES, Cruz ACR, Travassos da Rosa JFS. Aedes aegypti, dengue and re-urbanization of yellow fever in Brazil and other South American Countries - Past and present situation and future perspectives. World Health Organization, Dengue Bulletin (New Delhi) 23:55-66, 1999.
64. Vasconcelos PFC, Travassos da Rosa APA, Rodrigues SG, Travassos da Rosa ES, Monteiro HAO, Cruz ACR, Barros VLR, Souza MRS, Travassos da Rosa JFS. Yellow fever in Pará State, Amazon Region of Brazil, 1998-1999. Entomologic and epidemiologic findings. Emerging Infectious Disease 7:565-569, 2001.
65. Wang E, Weaver SC, Shope RE, Tesh RB, Watts DM, Barrett ADT. Genetic variation in yellow fever virus: duplication in the 3′ noncoding region of strains from Africa. Virology 225:274-281, 1996.
66. Westaway EG, Briton MA, Gaidamovich SY, Horzinek MC, Igarashi A, Kaariainen L, Lvov DK, Porterfield JL, Russell PK, Trent DW. Flaviviridae. Intervirology 24:183-192, 1985.
67. World Health Organization. Prevention and control of yellow fever in Africa, Geneva, 1985.
68. nd edition. World Health Organization, Geneva, 1997.
69. Xiao SY, Zhang H, Guzman H, Tesh RB. Experimental yellow fever virus infection in the Golden Hamster (Mesocricetus auratus). 2. Pathology. Journal of Infectious Diseases, 183:1437-1444, 2001.
70. Zanotto PMA, Gould EA, Gao GF, Harvey PH, Holmes EC. Population dynamics of flaviviruses revealed by molecular phylogenies. Proceedings of the National Academy of Sciences 93:548-553, 1996.